Strategic board

Jean-François ZAGURY, MD, PhD, Founder & CSO

Prof. Zagury graduated from Ecole Normale Superieure (Paris) and he then obtained his medical degree and his PhD in Immunology from Pierre and Marie Curie University. He has authored more than 100 publications in peer-reviewed international scientific journals and is inventor of 18 patents. He is currently chair professor of the Department of Bioinformatics at CNAM University, Paris. His laboratory was recently given an A+ evaluation by the French National Research Agency in all criteria, positioning it in the top 5% of French laboratories. He has the full support of his university to work on Peptinov’s project.

He was co-founder and CEO of Neovacs (ALNEV, EN Paris) from 1992 to 1998 and its CSO from 2001 to 2003. He founded Peptinov in 2009 to develop his works on anti-cytokine active immunization.

Thierry TEIL, MD, Co-founder

Dr. Thierry Teil (MD) is a seasoned professional in Pharmaceutical Industry and until recently served as VP Global Medical Affairs at NPS Pharmaceuticals (April 2014 – May 2015). In his role at NPS, he was responsible for building the Global Medical Affairs department, oversee Phase IIIB/IV, IIS and registries, provide medical input and leadership into all strategic and tactical dimensions of the company, supported the launch of Gattex/Revestive in Europe, Latin America, USA , and Canada; supported the launch of Natpara/Natpar worldwide.

Previously, he served at UCB Pharma from 2006-2014 and held executive responsibilities like VP Global Medical Affairs (2006-2009), and Managing Director Russia/CIS (2006-2014). He holds his expertise in late stage development, Medical Affairs, Marketing, Market Access, Emerging Markets, project leadership and alliance management. Prior to UCB, he served as Executive Director at The medicines Company, Angiomax ACS Project Leader and Head of Strategic Partnership and Alliance Management. He also served at Aventis and parent companies (now Sanofi) for 13 years with growing responsibilities in Global Marketing and Medical Affairs, Project Leadership and General Management. Thierry is also an entrepreneur, senior advisor at Triana Venture Partners, co-founder of International Regenerative Medicine Inc., and co-founder of Peptinov. He now acts as board member and strategic advisor for Peptinov.



René Azoulai is Peptinov’s CEO. He’s a graduate engineer from Ecole Polytechnique & Telecom ParisTech. He has more than 20 years of experience managing business units and innovative strategies in the fields of IT services and in the air transport industry, at senior executive level and on a worldwide scale. He has also been in charge of M&As and of an international joint venture operation.

René has been a significant investor in Peptinov since 2009, as well as a member of its board. Peptinov will greatly benefit from his managerial, strategic and business development experience during its current expansion phase, including on an international basis.